Open original FDA record ↗Recall record
- FDA identifier
- Z-0356-2007
- Company in FDA record
- Roche Diagnostics Corp.
- FDA classification date
- Jan 17, 2007
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Falsely elevated IGGT results may be reported because the R2 reagent of the Tina-quant Gen.2 albumin assay has a carryover effect on the Immunoglobulin G (turbidimetric) assay on the COBAS INTEGRA 700 and 800 analyzers and the R1 reagent of the Tina-quant Hemoglobin A1c assay has a carryover effect on the Immunoglobulin G (turbidimetric) assay on the COBAS INTEGRA 800 analyzer.
Source facts
- Action
- Device correction letters dated 12/15/06 instructing users to perform an extra wash cycle between applications when using both the ALBT2 and IGGT cassettes on the COBAS INTEGRA 700 and 800 analyzers. The recall was extended to via device correction letters dated 2/28/07 instructing users to perform an extra wash cycle between applications when using both the A1C2 and IGGT cassettes on the COBAS INTEGRA 800 analyzer.
- Initiated
- 2006-12-15
- Root cause
- Other
- Terminated
- 2008-04-23
- Distribution
- Nationwide.
- Recall number
- Z-0356-2007
- Recall status
- Terminated
- CDRH record ID
- 49521
- FDA classified
- 2007-01-17
- Recall event number
- 36887